MARGARET SACKMANN: Open Payments
NPI 1801814579 · TACOMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 7 payments from 5 companies in 2025. Trend: 2023 $307 · 2024 $0 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $250 |
| Neurocrine BioSciences, Inc. | 1 | $133 |
| Teva Pharmaceuticals USA, Inc. | 2 | $129 |
| Lilly USA, LLC | 1 | $95 |
| Amgen Inc. | 1 | $32 |
Products named: INGREZZA, AUSTEDO XR, KISUNLA.
Industry payments across WA — which companies pay providers there.
